Ayvens, a provider of sustainable mobility, delivered robust financial results for Q4 and full year 2024, marked by significant margin recovery, cost synergies, and progress in its integration roadmap ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

Cities are considering a new one-year service agreement for economic development services with the new organization, called ...

Stephanie Diaz; Investor Relations Manager; Viking Therapeutics Inc. Brian Lian; President, Chief Executive Officer, Director; Viking Therapeutics Inc. Greg Zante; C ...

Cantor Fitzgerald upgraded shares of Lam Research (NASDAQ:LRCX – Free Report) from a neutral rating to an overweight rating in a research note issued to investors on Thursday morning, MarketBeat.com ...

Equities researchers at B. Riley dropped their Q4 2025 EPS estimates for Lam Research in a research note issued on Thursday, January 30th. B. Riley analyst C. Ellis now forecasts that the ...

A City Council debate over whether a controversial pro-Gaza puppet display at the Chicago Cultural Center is antisemitic or a fair expression of free speech descended into disorder Tuesday, with an ...

Background: The COVID-19 pandemic period was associated with increased alcohol consumption. We sought to estimate excess ...

Supporters of gender-affirming care called on the University of Illinois health care system to be clearer and more ...